Explore real-world SMA scenarios through interactive questions focused on treatment durability, patient-reported changes, and long-term decision-making across pediatric and adult care.
6 questions
What is the most appropriate response to pre-dose strength/endurance decline with post-dose improvement?
Correct Answer: C
Pre-dose decline with post-dose improvement may suggest variability in perceived treatment effect across dosing intervals. Clinical reassessment—including timing of assessments, patient-reported outcomes, and overall treatment strategy—is recommended before considering changes to therapy.
https://www.sciencedirect.com/science/article/abs/pii/S1474442220300375
Fatigue and reduced endurance near the end of a dosing interval are best interpreted as what in adults with SMA?
Correct Answer: B
Stable motor scores do not exclude meaningful clinical change. Fatigue and reduced endurance may represent early or subtle changes that are not captured by standardized motor scales, highlighting the importance of incorporating patient-reported outcomes and functional assessments.
https://link.springer.com/article/10.1007/s00415-020-10227-5
Which combination best captures treatment durability in non-ambulatory adults with SMA?
Treatment durability in adults with SMA is best assessed using a multidimensional approach, including upper limb function (eg, RULM), functional and activities of daily living measures, respiratory assessments, and patient-reported outcomes to capture changes not reflected in motor scores alone.
https://journals.sagepub.com/doi/pdf/10.3233/JND-221595
Increasing procedural burden due to worsening scoliosis in a clinically stable patient should prompt what initial step?
Correct Answer: A
Changes in anatomy, such as worsening scoliosis, may affect treatment feasibility and patient burden. Reassessment of administration logistics, long-term adherence, and patient preference is recommended before making treatment changes.
https://www.sciencedirect.com/science/article/pii/S0960896617312841
Correct Answer: D
SMA affects multiple systems. A multidisciplinary approach—including motor, respiratory, bulbar and swallowing, and nutritional assessments—is essential for evaluating long-term treatment impact and disease progression.
https://www.nmd-journal.com/article/S0960-8966%2817%2931290-7/
Why might some patients receiving periodically administered disease-modifying therapies report fluctuations in fatigue or function between doses?
Some patients may report variability in perceived benefit across dosing intervals. This underscores the importance of integrating patient-reported experience with clinical assessments when evaluating treatment durability.